Q1 confirms lucrative timing of the offer
– Inderes
Tämä sisältö on vain Inderes Premium -käyttäjille.
Okmetic’s Q1 was challenging as our forecast was expecting. We believe the Q1 report and the weakening outlook in the semiconductor market confirm the lucrative timing of the tender offer. We continue to recommend owners to accept the offer by Chinese NSIG to acquire the company. We remind that ... |
Inderes Premium
Tämä sisältö on vain Inderes Premium -käyttäjille.